Trials / Conditions / Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
6 registered clinical trials studyying Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal C NCT03575234 | Emory University | Phase 1 |
| Active Not Recruiting | Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer NCT03468218 | Emory University | Phase 2 |
| Terminated | ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Tr NCT02917629 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Hea NCT02775812 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Recei NCT02381535 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recur NCT01064479 | M.D. Anderson Cancer Center | Phase 2 |